A 55-year-old Indian male smoker presents with a lung mass. Molecular analysis reveals KRAS mutation at codon 12. Which of the following is the most common type of lung cancer associated with KRAS mutations?

Question

Accepted Answer

D. Adenocarcinoma. ## KRAS Mutations in Lung Cancer

**Key Point:** KRAS mutations occur most frequently in lung adenocarcinoma (~30–40% of cases), particularly in non-smokers and smokers with peripheral lung tumors.

### KRAS Mutation Epidemiology in Lung Cancer

**High-Yield:** KRAS mutations show distinct associations with histologic subtypes:

| Lung Cancer Histotype | KRAS Mutation Frequency | Clinical Association |
| --- | --- | --- |
| Adenocarcinoma | 30–40% | Most common; peripheral location |
| Squamous cell carcinoma | 5–10% | Central airway; smoking-related |
| Small cell lung cancer (SCLC) | <5% | Rare; aggressive neuroendocrine |
| Large cell carcinoma | 10–15% | Uncommon histotype overall |

**Clinical Pearl:** KRAS-mutant adenocarcinomas tend to be more aggressive, with poorer prognosis and reduced responsiveness to EGFR inhibitors compared to EGFR-mutant tumors.

### Pathogenesis of KRAS-Driven Adenocarcinoma

1. KRAS mutation (codon 12 most common) occurs in peripheral lung epithelium
2. Constitutive RAS/MAPK pathway activation
3. Uncontrolled proliferation of mucin-producing cells
4. Development of adenocarcinoma phenotype
5. Progression to invasive and metastatic disease

**Mnemonic:** **KRAS in Adenocarcinoma = Kinase-driven Rapid Advancement in Smokers and non-smokers** — most common RAS isoform in lung adenocarcinoma.

### Why Adenocarcinoma is Most Common for KRAS

- Adenocarcinoma is the most common lung cancer subtype overall (~40% of lung cancers)
- KRAS mutations occur early in adenocarcinoma development
- Peripheral lung location favors adenocarcinoma histology
- KRAS activation drives mucin production and glandular differentiation

### Distinction from Other Molecular Drivers

| Molecular Driver | Associated Histotype | Frequency |
| --- | --- | --- |
| EGFR mutations | Adenocarcinoma | 10–15% (higher in non-smokers, Asians) |
| ALK translocation | Adenocarcinoma | 3–5% |
| KRAS mutations | Adenocarcinoma | 30–40% |
| TP53 mutations | All types (especially SCLC) | 50–90% |
| RB loss | SCLC | 90% |

**Warning:** ~~KRAS mutations are common in squamous cell carcinoma~~ — KRAS is much less frequent in squamous histology; squamous tumors more often have TP53 and SOX2 mutations.

[cite:Robbins 10e Ch 7]

Answer

A. Large cell carcinoma

Answer

B. Small cell lung cancer

Answer

C. Squamous cell carcinoma

A 55-year-old Indian male smoker presents with a lung mass. Molecular analysis reveals KRAS mutation at codon 12. Which of the following is the most common type of lung cancer associated with KRAS mutations?

Explanation

KRAS Mutations in Lung Cancer

KRAS Mutation Epidemiology in Lung Cancer

Pathogenesis of KRAS-Driven Adenocarcinoma

Why Adenocarcinoma is Most Common for KRAS

Distinction from Other Molecular Drivers

Practice similar questions

Join our NEET PG community

Lung Cancer Histotype	KRAS Mutation Frequency	Clinical Association
Adenocarcinoma	30–40%	Most common; peripheral location
Squamous cell carcinoma	5–10%	Central airway; smoking-related
Small cell lung cancer (SCLC)	<5%	Rare; aggressive neuroendocrine
Large cell carcinoma	10–15%	Uncommon histotype overall

Molecular Driver	Associated Histotype	Frequency
EGFR mutations	Adenocarcinoma	10–15% (higher in non-smokers, Asians)
ALK translocation	Adenocarcinoma	3–5%
KRAS mutations	Adenocarcinoma	30–40%
TP53 mutations	All types (especially SCLC)	50–90%
RB loss	SCLC	90%